Skip To Content

Study ID: ECOG-ACRIN EA8143

Title:

A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)

Location:
Bismarck Region, Fargo Region
Principal Investigator:
Preston Steen, MD,Preston Steen, MD
Disease:
REN (Renal)
Stage:
Phase III
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.